Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements

被引:22
作者
Romagnoli, Katrina M. [1 ]
Boyce, Richard D. [1 ]
Empey, Philip E. [2 ]
Adams, Solomon [2 ]
Hochheiser, Harry [1 ,3 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA 15206 USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15206 USA
[3] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA 15206 USA
关键词
Pharmacogenomics; Genomics; Needs assessment; Information needs; Qualitative inquiry; Pharmacists; DRUG INFORMATION; KNOWLEDGE-BASE; COMMUNITY PHARMACISTS; PERSONALIZED MEDICINE; PART I; IMPLEMENTATION; WARFARIN; PHARMGKB; GENOTYPE; CLOPIDOGREL;
D O I
10.1016/j.ijmedinf.2015.11.015
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Introduction: As key experts in supporting medication-decision making, pharmacists are well-positioned to support the incorporation of pharmacogenomics into clinical care. However, there has been little study to date of pharmacists' information needs regarding pharmacogenomics. Understanding those needs is critical to design information resources that help pharmacists effectively apply pharmacogenomics information. Objectives: We sought to understand the pharmacogenomics information needs and resource requirements of pharmacists. Methods: We conducted qualitative inquiries with 14 pharmacists representing 6 clinical environments, and used the results of those inquiries to develop a model of pharmacists' pharmacogenomics information needs and resource requirements. Results: The inquiries identified 36 pharmacogenomics-specific and pharmacogenomics-related information needs that fit into four information needs themes: background information, patient information, medication information, and guidance information. The results of the inquiries informed a model of pharmacists' pharmacogenomics resource requirements, with 3 themes: structure of the resource, perceptions of the resource, and perceptions of the information. Conclusion: Responses suggest that pharmacists anticipate an imminently growing role for pharmacogenomics in their practice. Participants value information from trust-worthy resources like FDA product labels, but struggle to find relevant information quickly in labels. Specific information needs include clinically relevant guidance about genotypes, phenotypes, and how to care for their patients with known genotypes. Information resources supporting the goal of incorporating complicated genetic information into medication decision-making goals should be well-designed and trustworthy. (C) 2015 Published by Elsevier Ireland Ltd.
引用
收藏
页码:54 / 61
页数:8
相关论文
共 58 条
  • [1] PharmGKB: a logical home for knowledge relating genotype to drug response phenotype
    Altman, Russ B.
    [J]. NATURE GENETICS, 2007, 39 (04) : 426 - 426
  • [2] Pharmacogenetic Testing: Time for Clinical Practice Guidelines
    Amstutz, U.
    Carleton, B. C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 924 - 927
  • [3] From expert-derived user needs to user-perceived ease of use and usefulness: A two-phase mixed-methods evaluation framework
    Boland, Mary Regina
    Rusanov, Alexander
    So, Yat
    Lopez-Jimenez, Carlos
    Busacca, Linda
    Steinman, Richard C.
    Bakken, Suzanne
    Bigger, J. Thomas
    Weng, Chunhua
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2014, 52 : 141 - 150
  • [4] Boyce R. D., 2013, AMIA SUMMITS TRANSL, V2, P28
  • [5] Genetic test evaluation: Information needs of clinicians, policy makers, and the public
    Burke, W
    Atkins, D
    Gwinn, M
    Guttmacher, A
    Haddow, J
    Lau, J
    Palomaki, G
    Press, N
    Richards, CS
    Wideroff, L
    Wiesner, GL
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (04) : 311 - 318
  • [6] Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
    Caudle, Kelly E.
    Klein, Teri E.
    Hoffman, James M.
    Mueller, Daniel J.
    Whirl-Carrillo, Michelle
    Gong, Li
    McDonagh, Ellen M.
    Sangkuhl, Katrin
    Thorn, Caroline F.
    Schwab, Matthias
    Agundez, Jose A. G.
    Freimuth, Robert R.
    Huser, Vojtech
    Lee, Ming Ta Michael
    Iwuchukwu, Otito F.
    Crews, Kristine R.
    Scott, Stuart A.
    Wadelius, Mia
    Swen, Jesse J.
    Tyndale, Rachel F.
    Stein, C. Michael
    Roden, Dan
    Relling, Mary V.
    Williams, Marc S.
    Johnson, Samuel G.
    [J]. CURRENT DRUG METABOLISM, 2014, 15 (02) : 209 - 217
  • [7] The needs and sources of drug information among pharmacists in Hong Kong
    Chan, TYK
    Lee, KKC
    Critchley, JAJH
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1996, 21 (05) : 325 - 330
  • [8] The Genetic Basis for Cancer Treatment Decisions
    Dancey, Janet E.
    Bedard, Philippe L.
    Onetto, Nicole
    Hudson, Thomas J.
    [J]. CELL, 2012, 148 (03) : 409 - 420
  • [9] de Denus S, 2013, PHARMACOGENOMICS, V14, P165, DOI [10.2217/PGS.12.197, 10.2217/pgs.12.197]
  • [10] de Graaff LCG, 2013, NETH J MED, V71, P145